Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Medical Microbiology
|
October 30, 2010
Q fever: the neglected biothreat agent
P C F Oyston, C Davies
Expert Opinion on Biological Therapy
|
July 2, 2003
A vaccine for tularaemia
R W Titball, P C F Oyston
Journal of Medical Microbiology
|
March 24, 2012
The natural history and incidence of Yersinia pestis and prospects for vaccination
E D Williamson, P C F Oyston
Clinical and Experimental Immunology
|
March 14, 2013
Protecting against plague: towards a next-generation vaccine
E D Williamson, P C F Oyston
Clinical and Experimental Immunology
|
August 11, 2019
A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens
A Abraham, G Ostroff, S M Levitz, et al.
Journal of Medical Microbiology
|
June 17, 2009
Novel peptide therapeutics for treatment of infections
P C F Oyston, M A Fox, S J Richards, et al.
Microbiology (Reading, England)
|
June 8, 2013
Synthetic biology: biology by design
M A J Roberts, R M Cranenburgh, M P Stevens, et al.
Journal of Medical Microbiology
|
December 6, 2002
Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins
S M Jones, J F Ellis, P Russell, et al.
Microbiology (Reading, England)
|
September 19, 2009
RelA regulates virulence and intracellular survival of Francisella novicida
R E Dean, P M Ireland, J E Jordan, et al.
Journal of Medical Microbiology
|
April 5, 2003
Expression of heterologous O-antigen in Yersinia pestis KIM does not affect virulence by the intravenous route
P C F Oyston, J L Prior, S Kiljunen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Medical Microbiology
|
October 30, 2010
Q fever: the neglected biothreat agent
P C F Oyston, C Davies
Expert Opinion on Biological Therapy
|
July 2, 2003
A vaccine for tularaemia
R W Titball, P C F Oyston
Journal of Medical Microbiology
|
March 24, 2012
The natural history and incidence of Yersinia pestis and prospects for vaccination
E D Williamson, P C F Oyston
Clinical and Experimental Immunology
|
March 14, 2013
Protecting against plague: towards a next-generation vaccine
E D Williamson, P C F Oyston
Clinical and Experimental Immunology
|
August 11, 2019
A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens
A Abraham, G Ostroff, S M Levitz, et al.
Journal of Medical Microbiology
|
June 17, 2009
Novel peptide therapeutics for treatment of infections
P C F Oyston, M A Fox, S J Richards, et al.
Microbiology (Reading, England)
|
June 8, 2013
Synthetic biology: biology by design
M A J Roberts, R M Cranenburgh, M P Stevens, et al.
Journal of Medical Microbiology
|
December 6, 2002
Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins
S M Jones, J F Ellis, P Russell, et al.
Microbiology (Reading, England)
|
September 19, 2009
RelA regulates virulence and intracellular survival of Francisella novicida
R E Dean, P M Ireland, J E Jordan, et al.
Journal of Medical Microbiology
|
April 5, 2003
Expression of heterologous O-antigen in Yersinia pestis KIM does not affect virulence by the intravenous route
P C F Oyston, J L Prior, S Kiljunen, et al.
Page
of 2